As public health experts, governments, and the WHO ask questions about the risks posed by AI, HBI speaks to two market experts. Should we be concerned or optimistic about its increasing use, specifically in health care?
Spanish insurer Sanitas and Italian insurer Generali are facing court action over a patient-sharing partnership affecting Spanish providers, which allegedly violates Spain’s competition rules.
The growing self-pay middle market in the UK is set to boom off the back of continuing NHS struggles, and patients' increasing willingness to pay for affordable alternatives. HBI speaks to multiple sources and hears groups accustomed to NHF tariff work could benefit most.
Plans to ban indirect private equity ownership of MVZ outpatient facilities in Germany would have a huge impact on radiotherapy according to an operator source and panellist at HBI 2023.
Headline grabbing French nursing home giant Orpea has made a drawdown of €200m from new financing, as it tries to restructure after a difficult 18 months.
Last week we reported how the result of the recent elections in Valencia means the Alzira model may yet survive in Spain. We speak to the CEO of the hospital group which pioneered that model to see what he thinks might happen next.
GenesisCare, the radiotherapy group with operations in the US, UK, Australia and Spain, has filed for voluntary reorganisation under chapter 11 of the US bankruptcy code and will look to sell off its US assets. HBI speaks to an advisory source to find out more.
Sweden’s government wants to place the country’s health care system under greater central government control. We speak to two Swedish health care experts to find out what this could mean.
The leftist government of Valencia has been routed in regional elections. Could this mean a restoration of the out-of-favour Alzira model of public-private partnership (PPP) hospitals? HBI speak to a consultant source to find out more.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.